2013-10-06 14:50:20 – Recently published research from Global Markets Direct, “Cempra, Inc. – Product Pipeline Review – 2013”, is now available at Fast Market Research
Global Market Direct’s pharmaceuticals report, “Cempra, Inc. – Product Pipeline Review – 2013” provides data on the Cempra, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Cempra, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Cempra, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
Full Report Details at
– www.fastmr.com/prod/689252_cempra_inc_product_pipeline_review_20 ..
Scope
* Cempra, Inc. – Brief Cempra, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline
of Cempra, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Cempra, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Cempra, Inc.’s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.
Reasons to Get this Report
* Evaluate Cempra, Inc.’s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Cempra, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Cempra, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Cempra, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Cempra, Inc. and identify potential opportunities in those areas.
Report Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
Cempra, Inc. Snapshot
Cempra, Inc. Overview
Key Information
Key Facts
Cempra, Inc. – Research and Development Overview
Key Therapeutic Areas
Cempra, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Cempra, Inc. – Pipeline Products Glance
Cempra, Inc. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Cempra, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Cempra, Inc. – Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Cempra, Inc. – Drug Profiles
fusidic acid
Product Description
Mechanism of Action
R&D Progress
Non-Antibiotic Macrolide Program for COPD
Product Description
Mechanism of Action
R&D Progress
Non-Antibiotic Macrolide Program for Gastric Disorders
Product Description
Mechanism of Action
R&D Progress
solithromycin
Product Description
Mechanism of Action
R&D Progress
Cempra, Inc. – Pipeline Analysis
Cempra, Inc. – Pipeline Products by Therapeutic Class
Cempra, Inc. – Pipeline Products By Target
Cempra, Inc. – Pipeline Products by Route of Administration
Cempra, Inc. – Pipeline Products By Mechanism of Action
Cempra, Inc. – Recent Pipeline Updates
Cempra, Inc. – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Cempra, Inc., Key Information
Cempra, Inc., Key Facts
Cempra, Inc. – Pipeline by Indication, 2013
Cempra, Inc. – Pipeline by Stage of Development, 2013
Cempra, Inc. – Monotherapy Products in Pipeline, 2013
Cempra, Inc. – Phase III, 2013
Cempra, Inc. – Phase II, 2013
Cempra, Inc. – Phase I, 2013
Cempra, Inc. – Preclinical, 2013
Cempra, Inc. – Pipeline By Therapeutic Class, 2013
Cempra, Inc. – Pipeline By Target, 2013
Cempra, Inc. – Pipeline By Route of Administration, 2013
Cempra, Inc. – Pipeline Products By Mechanism of Action, 2013
Cempra, Inc. – Recent Pipeline Updates, 2013
List of Figures
Cempra, Inc. – Pipeline by Indication, 2013
Cempra, Inc. – Pipeline by Stage of Development, 2013
Cempra, Inc. – Monotherapy Products in Pipeline, 2013
Cempra, Inc. – Pipeline By Therapeutic Class, 2013
Cempra, Inc. – Pipeline Products By Mechanism of Action, 2013
About Global Markets Direct
Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world’s top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.